Correlation Between Durect and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Durect and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Durect and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Durect and Carmell Therapeutics, you can compare the effects of market volatilities on Durect and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Durect with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Durect and Carmell Therapeutics.
Diversification Opportunities for Durect and Carmell Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Durect and Carmell is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Durect and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Durect is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Durect are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Durect i.e., Durect and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Durect and Carmell Therapeutics
Given the investment horizon of 90 days Durect is expected to generate 0.44 times more return on investment than Carmell Therapeutics. However, Durect is 2.25 times less risky than Carmell Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 153.00 in Durect on September 2, 2024 and sell it today you would lose (65.00) from holding Durect or give up 42.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Durect vs. Carmell Therapeutics
Performance |
| Timeline |
| Durect |
| Carmell Therapeutics |
Durect and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Durect and Carmell Therapeutics
The main advantage of trading using opposite Durect and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Durect position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Durect vs. Crinetics Pharmaceuticals | Durect vs. Enanta Pharmaceuticals | Durect vs. Amicus Therapeutics | Durect vs. Connect Biopharma Holdings |
| Carmell Therapeutics vs. Western Acquisition Ventures | Carmell Therapeutics vs. Bill Com Holdings | Carmell Therapeutics vs. Equinix | Carmell Therapeutics vs. Rumble Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |